The key question is what do we expect going forward both in the short and long-term timeframes with our Pharma business. As in our DX business we’re not sitting back. I am pleased to say that all indications are that we have won a large multiyear multi-million dollar NCI related award and we expect to begin realizing revenues from it in the third quarter or approximately even later in this quarter – that is second quarter of this year.
The CEO must be pretty sure about that comment....if not, why say it on the CC?
A real wild card here. What would be better? Ten years for $10 million or two years for $20 million. Both (and many other combinations) fit the vague description. End of Q 2 only 7 weeks away. If some revenues could fall into this 1/4, an agreement will have to be reached soon.
CEO put himself out on a limb here. Hope it works out.